Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis

References

• Albert MH, Liu Y, Anasetti C, Yu XZ. (2005). Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. Eur J Immunol, 35, 2598–607
   PubMed Web of Science ®Google Scholar
• Asano M, Toda M, Sakaguchi N, Sakaguchi S. (1996). Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med, 184, 387–96
   PubMed Web of Science ®Google Scholar
• Brummel R, Lenert P. (2005). Activation of marginal zone B cells from lupus mice with type A (D) CpG-oligodeoxynucleotides. J Immunol, 174, 2429–34
   PubMed Web of Science ®Google Scholar
• Carter NA, Vasconcellos R, Rosser EC, et al. (2011). Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol, 186, 5569–79
   PubMed Web of Science ®Google Scholar
• Chai JG, Xue SA, Coe D. (2005). Regulatory T cells, derived from naive CD4+CD25-T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation, 79, 1310–6
   PubMed Web of Science ®Google Scholar
• Choi YS, Jeong JA, Lim DS. (2012). Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T Cell-based immunosuppressive effect. Immunol Invest, 41, 214–29
   PubMed Web of Science ®Google Scholar
• Ding Q, Yeung M, Camirand G, et al. (2011). Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest, 121, 3645–56
   PubMed Web of Science ®Google Scholar
• Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. (2007). Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol, 178, 7868–78
   PubMed Web of Science ®Google Scholar
• Fillatreau S, Gray D, Anderton SM. (2008). Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol, 8, 391–7
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol, 4, 330–6
   PubMed Web of Science ®Google Scholar
• Garaud S, Le Dantec C, de Mendoza AR, et al. (2009). IL-10 production by B cells expressing CD5 with the alternative exon 1B. Ann NY Acad Sci, 1173, 280–5
   PubMedGoogle Scholar
• Garaud S, Morva A, Lemoine S, et al. (2011). CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT2 and NFAT2 activation. J Immunol, 186, 4835–44
   PubMed Web of Science ®Google Scholar
• Gray M, Miles K, Salter D, et al. (2007). Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA, 104, 14080–5
   PubMed Web of Science ®Google Scholar
• Haas KM, Watanabe R, Matsushita T, et al. (2010). Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol, 184, 4789–800
   PubMedGoogle Scholar
• Hori S, Nomura T, Sakaguchi S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057–61
   PubMed Web of Science ®Google Scholar
• Ibrahim L, Salah M, Rahman AAE, et al. (2013). Crucial Role of CD4+CD25+ FOXP3+ T regulatory cell, interferon-γ and interleukin-16 in malignant and tuberculous pleural effusions. Immunol Invest, 42, 122–36
   PubMed Web of Science ®Google Scholar
• Jaeckel E, von-Boehmer H, Manns MP. (2005). Antigen-specific Foxp3-transduced T-cells can control established type 1 diabetes. Diabetes, 54, 306–10
   PubMed Web of Science ®Google Scholar
• Kalampokis I, Yoshizaki A, Tedder TF. (2013). IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther, 15(S1), 1--12
   Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. (2003). An essential role for Scurfin in CD4+CD25+T regulatory cells. Nat Immunol, 4, 337–42
   PubMed Web of Science ®Google Scholar
• Lenert P, Brummel R, Field EH, Ashman RF. (2005). TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol, 25, 29–40
   PubMed Web of Science ®Google Scholar
• Loser K, Hansen W, Apelt J, et al. (2005). In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther, 12, 1294–304
   PubMedGoogle Scholar
• Maggi E, Cosmi L, Liotta F, et al. (2005). Thymic regulatory T cells. Autoimmun Rev, 4, 579–86
   PubMed Web of Science ®Google Scholar
• Maseda D, Smith SH, DiLillo DJ, et al. (2012). Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol, 188, 1036–48
   PubMedGoogle Scholar
• Matsushita T, Yanaba K, Bouaziz Z-D, et al. (2008). Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest, 118, 3420–30
   PubMed Web of Science ®Google Scholar
• Mauri C, Bosma A. (2012). Immune regulatory function of B cells. Annu Rev Immunol, 30, 221–41
   PubMed Web of Science ®Google Scholar
• Mauri C, Ehrenstein MR. (2008). The ‘short' history of regulatory B cells. Trends Immunol, 29, 34–40
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Mizoguchi E, Takedatsu H, et al. (2002). Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity, 16, 219–30
   PubMed Web of Science ®Google Scholar
• Pistoia V. (1997). Production of cytokines by human B cells in health and disease. Immunol Today, 18, 343–50
   PubMedGoogle Scholar
• Sakaguchi S, Sakaguchi N, Asano M, et al. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 155, 1151–64
   PubMed Web of Science ®Google Scholar
• Schioppa T, Moore R, Thompson RG, et al. (2011). B regulatory cells and the tumor-promoting actions of TNF-alpha during squamous carcinogenesis. Proc Natl Acad Sci USA, 108, 10662–7
   PubMed Web of Science ®Google Scholar
• Shevach E. (2000). Regulatory T cells in autoimmunity. Annu Rev Immunol, 18, 423–49
   PubMed Web of Science ®Google Scholar
• Tadmor T, Zhang Y, Cho HM, et al. (2011). The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model. Cancer Immunol Immunother, 60, 609–19
   Google Scholar
• Velaga S, Ukena SN, Hpting M, et al. (2013). Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation. Immunol Invest, 42, 18–25
   PubMed Web of Science ®Google Scholar
• Xing Q, Su H, Cui J, Wang B. (2012). Role of Treg cells and TGF-beta1 in patients with Systemic Lupus Erythematosus: A possible relation with Lupus Nephritis. Immunol Invest, 41, 15–27
   PubMed Web of Science ®Google Scholar
• Yanaba K, Bouaziz JD, Haas KM, et al. (2008). A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T celldependent inflammatory responses. Immunity, 28, 639–50
   PubMed Web of Science ®Google Scholar
• Yanaba K, Bouaziz J-D, Matsushita T, et al. (2009). The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol, 182, 7459–72
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang L, Zhang M, Lv K. (2014). Galectin-9 induced myeloid suppressor cells expand regulatory T cells in an IL-10-dependent manner in CVB3-induced acute myocarditis. Int J Mol Sci, 15, 3356–72
   PubMedGoogle Scholar